Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mFOLFOX6 with or without HAI Floxuridine in unresectable colorectal liver metastasis
NCT02102789Phase 3Recruiting
- Start
- Mar 2014
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of floxuridine in colorectal cancer (CRC). Started Mar 2014; status: recruiting.
02
Drugs
floxuridine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02102789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02102789.